TRUTOL Glucose Tolerance Beverage
Dietary SupplementA caffeine-free, non-carbonated, glucose tolerance beverage
NCT Number: NCT03138902
The purpose of this study is to evaluate the validity of using a carbohydrate intolerance questionnaire (CIQ) and/or other health markers as a means of predicting response to insulin sensitivity as determined by an oral glucose tolerance test (OGTT).
Looking for future studies?
Notify Me18 year–60 year
Female
Interventional
Not applicable
This study will utilize a carbohydrate intolerance questionnaire (CIQ). Responses to a CIQ will be correlated with diet inventories, baseline body composition and health assessments, a standard metabolic panel, fasting glucose and insulin levels, a homeostatic insulin resistance model (HOMA), a two hour oral glucose tolerance test (OGTT), and a carbohydrate sensitivity symptom questionnaire administered during the OGTT.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A caffeine-free, non-carbonated, glucose tolerance beverage
Time frame: 1 day
Primary Outcome
Time frame: 2 hours
Primary Outcome
Time frame: 2 hours
Primary Outcome
Texas A&M University
Other
Validation of Carbohydrate Intolerance Questionnaire
Acronym: Curves1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04456166
Carbohydrate Intolerance, Diabetes Mellitus
Seoul, Jongnogu, South Korea
View Trial DetailsNCT03667963
Carbohydrate Intolerance, Glucose-Galactose Malabsorption
Toronto, Ontario, Canada
View Trial DetailsNCT03506581
BETA-CELL FUNCTION, Body Composition
View Trial DetailsNCT03015506
Carbohydrate Intolerance, Glucose-Galactose Malabsorption
View Trial Details